Pharm Tech Minutes 2012.10.24

09:00 - 09:30 Welcome

• Welcome

• Call to Order/Roll Call

• IHE

• Juergen Brandstaetter
• Jacqueline Surugue
• Michael Tan
• Marc Robberecht
• Eric Poiseau
• Leonidas Tzimis
• Simon Letellier
• Jose Costa Teixeira
• Stephen Chu

• HL7

• Tom de Jong
• Melva Peters
• Jean Duteau
• Nicolas Canu
• Hugh Glover
• Julie James

• Review and Approve Agenda

• Approved

09:30 - 10:00 Wrap-up last year

• Progress since the last meeting and forward plans on each side

• HL7

• Prepared topics in HL7 Pharmacy for ballot (extensive process)

• Some already normative, others still in progress

• HL7 V3 Pharmacy material formerly intended to be used in Community Pharmacy, but now also prepared for Institutional Pharmacy (= Hospital Pharmacy). This work is almost finished.
• Work on Medication profile work-item

• Proposals for future work/collaboration

• Work on storyboards could be shared or beind done collaborated, because they are usually the same
• How do we make sure that people adopt the standards of HL7 and IHE since that pair results in the "way to use all the material in the right way"?

• Todo: Jürgen will provide a slide with the statement, will be shaped between the co-chairs until suitable

• IHE

• Maintenance of profiles

• No big changes, exceptional cases added

• Doing marketing for Deployment
• Collaborative work with PCD according "Administration devices"
• Work on Medication Documentation
• IHE International strategic change

10:00 - 12:15 Strategie for increasing adoption and deployment of both IHE and HL7

• Tom presents the layers of interoperability

• TRANSPORT

• XDS, AORTA, ...

• PACKAGING

• Messages, CDA

• CONTENT

• Data model, Terminology

• CONCEPTS (hard to standardize by HL7 or IHE)

• Semantics, Glossary

• Discussion about enhancing the flexibilty of IHE profiles in order to also fit to "message-based" archtictures, e.g. Cananda

• We realized that also the Canada topology contains also a central repository and therefore it's not that much different to the CMPD model, except that CMPD relies on XDS only at the moment

• In order to do that there are the following Todos:

• New IHE work-item: Will check the separation of CMPD actors into "Content Creator" and "Transport" actors and evaluates if the grouping with XDR/XDM would also be possible

• Jürgen

• New Joint work-item: "Standardized content": Agree on a common data model for e.g. Prescription and subsequently decide if to change/enhance PRE profile or create an alternative second content profile (similar for other content types)

• Jürgen, Tom

• Evaluate the creation of a CMPD.b profile which shall be consider topologies without central repository (e.g. US approach of sending the prescription directly to the Pharmacy)

• We agree that this is main difference in topology (central registry existing or not)
• Considered as important but second priority. Postponed until first item is completed

13:00 - 14:30 Medication Profile (with break)

• Yesterday's outcome

• Proposal for continuing tomorrow:

• 1) Approve the hierarchy of Stephen's slides
• 2) Discuss and approve each definition within the hierarchy
• 3) Define next steps

• Review of Stephen's presentation

• Decisions

• Terms have to harmonized in a glossary in context of their usage
• Glossary will be done during shaping the definitions
• Use-cases shall be created and shall come from a wide community
• Parallel to the work on the hierarchy/definitions a second work-item will be worked our bottom-up and which describes data-sources and the according nature of the data as well as related aspects necessary to provide the data needed by the other work-item
• The term "reconsiliation" has two meanings:

• 1) Matching data with reality (e.g. by asking the patient)
• 2) Finding the right future medication by considering the past medication and clinical situation of the patient
• Agreed term for (1): Medication Reconsiliation
• Agreed term for (2): Medication Revision

• Todo

• Stephen will consolidate the slide deck and combines the terms in the hierarchy with the definitions formerly sent. Will send to both groups when done (within 2 weeks)
• Jacqueline, Stephen, Melva, Leonidas will provide use-cases, Michael reviews
• Jose takes the lead of the second work-item. Approved that work on this work-item may start immediately.

• Next steps

• Wait for Stephen's slides
• Jacqueline on behalf of all use-case makers will communicate the decision if a TCon is needed before use-cases will be created (within 2 weeks after slides received)

15:15 - 16:00 Pharmacy CDA Mapping Project

• Introduction of project

• Primary goal: Mapping of HL7 Pharmacy Message Types information elements to suitable CDA R2 information elements
• Second goal: Stylesheet for automatic generation

• Interest in following or participating?

• Collaborative work implicitly given by work-item "Standardized content" and following work-items
• Extend CDA Schema (for IHE Pharmacy) will be provided to Tom and Michael
• Michael will check if NICTIZ could provided resources for doing the mapping
• Suggested tool for mapping: Altova MapForce (or similars)

16:00 - 16:15 Review of recent change in Pharmacy CMET in 2011

• See CP-PHARM-035

• ftp://iheyr2@ftp.ihe.net/Pharmacy/TF_Maintenance-2013/CPs/Assigned/CP-PHARM-035.doc

• Are there any more changes to expect in the near future?

• Yes, it's because Substances became a section of the Common Product Model
• Recommendation of HL7 Pharmacy: Wait at least to Common Product Model Release 12 (currently Rel 10)

• Release Number does not correspond to Normative Edition numbering!

16:15 - 16:30 Glossary work item

• Status

• Marco and Derrek Evans have worked on it
• No information about the current status
• Expected end of the work-item can not be estimated because work on it is on hold at the moment

• Yesterday's outcome

• Sync with ISO Glossary (SKMT) necessary?

• Discussion

• Melva: It's not clear, if this is globally well accepted. It's more a "gathering" tool which allows multiple definitions for terms without governance
• Nicolas: SKMT names itself "Glossary" but its rather a dictionary. A glossary should always be seen in some context

• Decision

• Should definately be used as a source for our common glossary
• Contributing our terms to SKMT once we decided on our preferred definitions

16:30 - 17:00 Any other business

• ISO plans a new work item "Drug dictionary" - what is our standpoint?

• Julie reports

• A small group will prepare a proposal for the "Requirements of a drug dictionary"
• Not clear if an international or national drug dictionary?

• Discussion

• Hugh: It's inapproriate to begin such a piece of work when the IDMP standard (referred by the new item) is not yet finalized.
• Jacqueline: The requirements differ a lot even within countries.

• Decision

• Wait for the actual proposal

• Frank Gener sends PHAST document: "The Functional Interoperability Framework for Automated Systems Integration in Electronic Medication Management Processes"

• IHE identifies this document to be related to HMW and Supply Chain

• Mostly already covered by the Supply Chain Whitepaper, because of synchronized work in the past
• Document will be put to FTP in subfolder "Resources" to folder "Supply Chain" whitepaper

• HL7

• Document will be published internally
• Will be evaluated in the future

Next meetings

• IHE

• F2F meeting in March 18-19, 2013 at Arsenal-IT, Treviso, Italy
• IHE offer to HL7:

• Join our meeting on the 19th and HL7 adds 2 days for you own
• Is expected not to be problem for Arsenal-IT

• Todo Jürgen: Will contact Claudio if it's possible and inform HL7 co-chair

• F2F meeting in June 11-12, 2013 at Nictiz, Den Haag, Netherlands
• IHE offer to HL7:

• Join our meeting on the 12th and HL7 adds 2 days for you own
• Nictiz confirms this possibility

• No F2F meetings are defined for season yet

• IHE would be willing to plan March's and October's meeting together with HL7 in order to do a joint day on both
• IHE also has access to quite some locations (sponsored) which could also be extended to HL7 group

• HL7

• No future out-of-cycle meetings planned
• March could be possible
• Decision most likely not before Jan 2013

• Regulary meetings:

• Jan 13-18, 2013, Phoenix
• May 5-10, 2013, Atlanta
• Sep 22-27, 2013, Camebridge/Massachussets